{
    "name": "omacetaxine",
    "comment": "Rx",
    "other_names": [
        "Synribo"
    ],
    "classes": [
        "Antineoplastics",
        "Protein Synthesis Inhibitors"
    ],
    "source": "https://reference.medscape.com/drug/synribo-omacetaxine-999786",
    "pregnancy": {
        "common": [
            "Based on mechanism of action and findings from animal studies, therapy can cause fetal harm when administered to pregnant women",
            "There are no available data on pregnant women to evaluate for a drug- associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes; advise pregnant women of potential risk to a fetus",
            "Pregnancy testing is recommended for females of reproductive potential prior to initiating therapy"
        ],
        "specific": [
            {
                "type": "Infertility",
                "description": [
                    "  ",
                    "  ",
                    "Based on findings from animal studies, therapy may impair male fertility; studies in mice demonstrated adverse effects on male reproductive organs where bilateral degeneration of seminiferous tubular epithelium in testes and hypospermia/aspermia were observed; long-term effects on male fertility, including reversibility of adverse effects, not studied"
                ]
            },
            {
                "type": "Contraception",
                "description": [
                    "  ",
                    "  ",
                    "Drug can cause embryo-fetal harm when administered to pregnant women; advise female patients of reproductive potential to use effective contraception during treatment and for 6 months after final dose",
                    "  ",
                    "  ",
                    "Based on genotoxicity findings, advise males with female partners of reproductive potential to use effective contraception during treatment and for 3 months after final dose."
                ]
            },
            {
                "type": "Animal data",
                "description": [
                    "Drug can cause embryo-fetal harm when administered to pregnant women; advise female patients of reproductive potential to use effective contraception during treatment and for 6 months after final dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on presence of drug in either human or animal milk, effects on breastfed child, or on milk production; because of potential for serious adverse reactions in breastfed child, advise patients that breastfeeding is not recommended during treatment and for 2 weeks after final dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Monitor CBC panel for myelosuppression",
                "Grade 3/4 neutropenia, thrombocytopenia and anemia commonly occur; avoid use of anticoagulants, aspirin, and NSAIDs when platelet count is <50,000/ mmÂ³",
                "Therapy may induce glucose intolerance; monitor glucose levels frequently, especially in patients with diabetes or with risk factors for diabetes; avoid use in patients with poorly controlled diabetes; may initiate after glycemic control established",
                "Avoid pregnancy"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Thrombocytopenia",
            "percent": "74"
        },
        {
            "name": "Anemia",
            "percent": "61"
        },
        {
            "name": "Neutropenia",
            "percent": "50"
        },
        {
            "name": "Infections and infestations",
            "percent": "46"
        },
        {
            "name": "Diarrhea",
            "percent": "42"
        },
        {
            "name": "Injection site reactions",
            "percent": "34"
        },
        {
            "name": "Nausea",
            "percent": "32"
        },
        {
            "name": "Fatigue",
            "percent": "26"
        },
        {
            "name": "Pyrexia",
            "percent": "24"
        },
        {
            "name": "Asthenia",
            "percent": "23"
        },
        {
            "name": "Arthralgia",
            "percent": "19"
        },
        {
            "name": "Headache",
            "percent": "19"
        },
        {
            "name": "Lymphopenia",
            "percent": "17"
        },
        {
            "name": "Cough",
            "percent": "16"
        },
        {
            "name": "Alopecia",
            "percent": "15"
        },
        {
            "name": "Constipation",
            "percent": "15"
        },
        {
            "name": "Epistaxis",
            "percent": "15"
        },
        {
            "name": "Abdominal pain",
            "percent": "14"
        },
        {
            "name": "upper",
            "percent": "13"
        },
        {
            "name": "Pain in extremities",
            "percent": "13"
        },
        {
            "name": "Peripheral edema",
            "percent": "12"
        },
        {
            "name": "Vomiting",
            "percent": "11"
        },
        {
            "name": "Back pain",
            "percent": "4"
        },
        {
            "name": "Hyperglycemia",
            "percent": "11"
        },
        {
            "name": "grade",
            "percent": "10"
        },
        {
            "name": "Bone marrow failure",
            "percent": "10"
        },
        {
            "name": "Febrile neutropenia",
            "percent": "10"
        },
        {
            "name": "Insomnia",
            "percent": "10"
        },
        {
            "name": "Rash",
            "percent": "56"
        },
        {
            "name": "Thrombocytopenia",
            "percent": "56"
        },
        {
            "name": "Infections and infestations",
            "percent": "51"
        },
        {
            "name": "Anemia",
            "percent": "35"
        },
        {
            "name": "Diarrhea",
            "percent": "31"
        },
        {
            "name": "Fatigue",
            "percent": "29"
        },
        {
            "name": "Pyrexia",
            "percent": "27"
        },
        {
            "name": "Nausea",
            "percent": "24"
        },
        {
            "name": "Asthenia",
            "percent": "22"
        },
        {
            "name": "Injection site reactions",
            "percent": "20"
        },
        {
            "name": "Febrile neutropenia",
            "percent": "20"
        },
        {
            "name": "Neutropenia",
            "percent": "15"
        },
        {
            "name": "Cough",
            "percent": "15"
        },
        {
            "name": "Vomiting",
            "percent": "13"
        },
        {
            "name": "Abdominal pain",
            "percent": "13"
        },
        {
            "name": "Anorexia",
            "percent": "13"
        },
        {
            "name": "Chills",
            "percent": "13"
        },
        {
            "name": "Headache",
            "percent": "11"
        },
        {
            "name": "Dyspnea",
            "percent": "11"
        },
        {
            "name": "Epistaxis",
            "percent": "11"
        },
        {
            "name": "Pain in extremities",
            "percent": null
        },
        {
            "name": "Myelosuppression",
            "percent": null
        },
        {
            "name": "Bleeding",
            "percent": null
        }
    ]
}